Clinical Investigation of Erlotinib as an HCV Entry Inhibitor
Clinical trial NCT01835938 · UNKNOWN
Trial details
- NCT number
- NCT01835938
- Sponsor
- University Hospital, Strasbourg, France
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.